Find uplifting stories about heroes, innovations, and solutions
40 results for "hpv"
Blood tests now identify what's causing head and neck cancers, letting doctors tailor treatments that work better with fewer harsh side effects. Patients like Wendy Jackson are beating aggressive cancers and returning to normal life faster than ever before.
Researchers developed a chewing gum from lablab beans that reduced cancer-linked microbes by up to 93% in patient samples. The gum targets harmful bacteria without affecting the good microbes in your mouth.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
A new $114,000 program gives younger head and neck cancer survivors stress management tools they can use anytime, anywhere. The self-guided digital platform tackles the unique challenges faced by working-age survivors balancing recovery with jobs and families.
After surviving cervical cancer through expensive treatment abroad, Irakoze Gratia celebrates as Burundi launches free HPV vaccines for girls. The preventable disease kills over 1,000 Burundian women each year.
A landmark study shows South Africa's free school vaccination program slashed HPV infections by 83%, proving the vaccine works even in regions with high HIV rates. For the first time, researchers confirmed that early vaccination protects girls living with HIV just as well as those without it.
Cancer deaths in the UK have fallen to their lowest level ever recorded, with a nearly 29% drop since 1989. Decades of investment in screening, vaccines, and new treatments are saving lives across nearly every major cancer type.
Scientists in Mexico have successfully eliminated the virus that causes cervical cancer in patients using a groundbreaking light-based treatment. The therapy could offer new hope to millions of women worldwide who currently have limited options after HPV infection.
Panama became the first country in Latin America to offer universal HPV vaccination, and it's working. Cervical cancer rates have been steadily falling since the program launched, with vaccine coverage now exceeding 85 percent.
India is rolling out a nationwide HPV vaccination campaign starting February 28 to protect 14-year-old girls from cervical cancer, which kills 75,000 Indian women every year. The free vaccine will be available at 30,000 centers across the country.
A groundbreaking 18-year study from Sweden shows the HPV vaccine provides lasting protection against cervical cancer, with no signs of weakening over time. Nearly a million women participated in research that could help eliminate cervical cancer as a public health threat.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
Scientists have developed a therapeutic vaccine that successfully fought HPV-related cancers in mice, offering hope for patients with advanced disease. Unlike current vaccines that only prevent infection, this treatment targets existing tumors.
Scientists have designed a cancer vaccine that successfully fought HPV-related throat tumors in mice, offering hope for people battling these aggressive cancers. The breakthrough lies in how the vaccine's components are arranged, making it more effective at training the immune system to recognize and destroy cancer cells.
A routine hospital screening saved Anathalie Mukamanzi's life when doctors discovered cervical cancer she'd dismissed as exhaustion. Her story is helping Rwanda push toward eliminating the disease three years ahead of global targets.
Ghana has protected nearly 1.9 million girls against HPV, the virus that causes cervical cancer, reaching 80% of girls aged 9 to 14. Schools became powerful health hubs, with 90% of vaccinations happening in classrooms across the country.
Scientists in China discovered that testing menstrual blood for cancer-causing HPV works just as well as traditional pelvic exams. The breakthrough could help millions who avoid screenings due to discomfort, trauma, or accessibility barriers.
A new health report reveals that Nigeria's 46,000 annual cancer deaths among women stem from policy failures, not medical limits. Countries like Rwanda prove early detection and prevention can dramatically reduce mortality rates.
Nigeria's Jigawa State is protecting girls from cervical cancer with free HPV vaccines, a move that could save thousands of lives. Health officials are reassuring parents the vaccine is safe and used worldwide.
Showing 20 of 40